ID
22302
Descripción
Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Subject Status / Response Assessment, 6 Month Post-Therapy Follow-up Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast
Link
https://clinicaltrials.gov/ct2/show/NCT00078572
Palabras clave
Versiones (1)
- 29/5/17 29/5/17 -
Subido en
29 de mayo de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
Descripción
Response Assessment
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
- UMLS CUI-3
- C0678222
Descripción
If NO, complete the rest of this page.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0242656
Descripción
lesion
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0221198
- UMLS CUI [1,3]
- C0220825
Descripción
Response assessment
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0521982
Descripción
method
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0871511
- UMLS CUI [1,2]
- C0221198
- UMLS CUI [1,3]
- C0220825
Descripción
If Symptomatic progression of cancer is checked, complete details below
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0178874
Descripción
Specify symptoms
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0178874
Similar models
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
C1522577 (UMLS CUI-2)
C0678222 (UMLS CUI-3)
C0920425 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0678222 (UMLS CUI-3)
C0221198 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,3])
C0221198 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,3])
C0178874 (UMLS CUI [1,2])
C0178874 (UMLS CUI [1,2])